Genedata Advances R&D Efficiency with New Unified Sample Management Solution

Fully integrated biological sample management enables precise and efficient tracking of physical samples, their storage locations, and their histories across the full sample life cycle, including production, aliquoting, barcoding, distribution, and final disposal

BASEL, Switzerland, Aug. 28, 2025 /PRNewswire/ -- Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of a new Sample Management module as part of their Genedata Biopharma Platform. The Genedata Biopharma Platform is the industry's leading platform for discovering and developing novel biotherapeutics, covering the full end-to-end workflow from therapeutics design and engineering to process development. It supports a broad range of therapeutic modalities out of the box, including novel modalities such as multi-specifics, Antibody Drug Conjugates (ADCs), Cell and Gene Therapies, and RNA-LNPs.

Biotherapeutics R&D involves managing a high volume of samples such as plasmids, cell banks, and purified proteins produced by different groups and stored in freezers or cryobanks at different sites. Sample tracking, often relying on local, decentralized, or home-grown inventory software, is time-consuming, costly, and prone to errors.

Genedata's new Sample Management solution addresses this challenge by offering a dedicated new module for managing the precise physical location of each sample across different groups and sites, down to the building, shelf, and container. This ensures accurate tracking of each sample, enabling compliant and efficient inventory control, sample storage, location, requesting, and distribution. By being directly integrated with the Genedata bioregistration engine, the content and history of all samples are accessible at any time, whether it is a protein, plasmid, cell line, or complex mixture.

What makes this solution unique is its seamless integration within the Genedata Biopharma Platform, including Genedata Biologics^® and Genedata Bioprocess^®. This allows sample location data to be automatically linked with all relevant contextual information and metadata such as batch records, molecule properties, genealogy, and assay or QC results. No other software on the market offers this level of connectivity and information traceability within a single, fully integrated platform. By eliminating the need for external inventory systems, system integration, or data synchronization, it provides a unified, reliable source of truth for all biological samples.

Developed in close collaboration with leading biopharma partners, the new module combines robustness with ease of use. It supports configurable inventory hierarchies tailored to diverse laboratory environments, downloadable storage views for collaboration, and container dashboards for placing and retrieving aliquots. Importantly, all sample inventory and ordering processes can be fully automated. With sample quantity tracking capabilities, it adds spatial awareness and operational control to further improve efficiency and reduce risk.

"Recognizing the limitations of existing inventory and sample management solutions, we set out to build a fully integrated module designed to transform laboratory logistics," said Othmar Pfannes, Ph.D., President of Genedata. "Our goal is to pave the way for fully automated workflows that bring new levels of efficiency and precision to R&D. With this module, customers can manage their samples and inventories with the same rigor they apply to molecule and cell line registration, ensuring complete traceability for every sample and streamlining the R&D workflow through a trusted central data source."

About Genedata
Genedata, a Danaher company, transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.

www.genedata.com
LinkedIn | YouTube

About Danaher
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology – and proven ability to innovate – help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

SOURCE Genedata